REPORTS

Let’s Pullulate and Expand Your Business

Antidiabetics Market - Global Professional Analysis and Forecast to 2026

Oct 12, 2019  |  184 PAGES  |  REPORT CODE: CMM205835
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Antidiabetics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.3% during the forecast period.

This report presents the market size and development trends by detailing the Antidiabetics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antidiabetics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antidiabetics industry and will help you to build a panoramic view of the industrial development.

Antidiabetics Market, By Type:

  • Biguanides

  • Thiazolodinediones

  • GLP-agonists

  • Sulphonylureas

  • DPP-4 inhibitors

  • SGLT-2

  • Alpha-glucosidase Inhibitors

  • Meglitinides

Antidiabetics Market, By Application:

  • Hospitals & Clinics

  • Retail pharmacies

  • Online sales

Some of the leading players are as follows:

  • Bioton S.A

  • Novo Nordisk

  • Takeda Pharmaceuticals

  • Pfizer

  • Halozyme Therapeutics

  • Nanjing Xinbai

  • Oramed Pharmaceuticals

  • Shenzhen Kexing

  • Jiangsu Wanbang

  • Eli Lilly

  • Sanofi-Aventis

  • Boehringer Ingelheim

  • Merck & Co. Inc

  • SPH NO.1 Biochemical & Pharma

  • Bristol-Myers Squibb

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Antidiabetics Market: Technology Type Analysis

  • 4.1 Antidiabetics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Antidiabetics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Biguanides

    • 4.3.2 Thiazolodinediones

    • 4.3.3 GLP-agonists

    • 4.3.4 Sulphonylureas

    • 4.3.5 DPP-4 inhibitors

    • 4.3.6 SGLT-2

    • 4.3.7 Alpha-glucosidase Inhibitors

    • 4.3.8 Meglitinides

5 Antidiabetics Market: Product Analysis

  • 5.1 Antidiabetics Product Market Share Analysis, 2018 & 2026

  • 5.2 Antidiabetics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Antidiabetics Market: Application Analysis

  • 6.1 Antidiabetics Application Market Share Analysis, 2018 & 2026

  • 6.2 Antidiabetics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals & Clinics

    • 6.3.2 Retail pharmacies

    • 6.3.3 Online sales

7 Antidiabetics Market: Regional Analysis

  • 7.1 Antidiabetics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Antidiabetics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Bioton S.A

    • 9.1.1 Bioton S.A Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novo Nordisk

    • 9.2.1 Novo Nordisk Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Takeda Pharmaceuticals

    • 9.3.1 Takeda Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pfizer

    • 9.4.1 Pfizer Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Halozyme Therapeutics

    • 9.5.1 Halozyme Therapeutics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Nanjing Xinbai

    • 9.6.1 Nanjing Xinbai Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Oramed Pharmaceuticals

    • 9.7.1 Oramed Pharmaceuticals Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Shenzhen Kexing

    • 9.8.1 Shenzhen Kexing Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Jiangsu Wanbang

    • 9.9.1 Jiangsu Wanbang Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Eli Lilly

    • 9.10.1 Eli Lilly Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sanofi-Aventis

    • 9.11.1 Sanofi-Aventis Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Boehringer Ingelheim

    • 9.12.1 Boehringer Ingelheim Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Merck & Co. Inc

    • 9.13.1 Merck & Co. Inc Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 SPH NO.1 Biochemical & Pharma

    • 9.14.1 SPH NO.1 Biochemical & Pharma Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Bristol-Myers Squibb

    • 9.15.1 Bristol-Myers Squibb Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 85 Figures and 163 Tables)

  • Figure Biguanides Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure Thiazolodinediones Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure GLP-agonists Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure Sulphonylureas Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure DPP-4 inhibitors Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure SGLT-2 Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure Alpha-glucosidase Inhibitors Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure Meglitinides Antidiabetics market, 2015 - 2026 (USD Million)

  • Figure Hospitals & Clinics market, 2015 - 2026 (USD Million)

  • Figure Retail pharmacies market, 2015 - 2026 (USD Million)

  • Figure Online sales market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Antidiabetics market, by country, 2015 - 2026 (USD Million)

  • Table North America Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table North America Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table North America Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Antidiabetics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table France Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table France Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antidiabetics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table China Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table China Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table India Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table India Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Antidiabetics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Antidiabetics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Antidiabetics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Antidiabetics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Antidiabetics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Bioton S.A Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Halozyme Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nanjing Xinbai Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Oramed Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shenzhen Kexing Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jiangsu Wanbang Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi-Aventis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co. Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SPH NO.1 Biochemical & Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top